New “fast, accurate” COVID sensor developed

A COVID-19 sensor developed at Johns Hopkins University could revolutionise virus testing.

Ten-second videos predict blood cancer relapse

In a new study, 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.

AI potential for breast cancer screening

A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programmes.

New test predicts sepsis before blood clots

The findings provide a platform to develop rapid and easy-to-perform clinical tests for early sepsis detection and clinical intervention in human patients.

Eye scanner targets neurodegenerative diseases

It is hoped that this will enable neurodegenerative diseases to be detected at an early stage, as well as eye diseases and diabetes.

“Personalised testing needed for safety”

The statement comes from a report – Personalised prescribing: using pharmacogenomics to improve patient outcomes – by the British Pharmacological Society and the Royal College of Physicia

Expanding the target range of crispr/cas systems

This could help realise the potential of CRISPR/Cas-based gene therapy and pathogen diagnosis, it is claimed.

The Scientific Laboratory Show and Conference 2022

Working in partnership with the Science Council, the show is free to attend at the East Midlands Conference Centre in Nottingham with doors opening at 9am and closing at 5pm.  

“Diabetes in COVID-19 patients may be transitory”

Normal blood sugar levels may return soon after discharge, a study has found.

Under the microscope: The Gambela

What is the Gambela?